PeliPartners has advised the Argo Capital Property group on the sale of the Shopping City Suceava mall. Argo Capital is a ...
Shelby Knowles / Bloomberg via Getty Images Eli Lilly's Zepbound can be covered by Medicare Part D plans after the FDA approved the drug as a treatment for sleep apnea last month. Weight loss ...
The FDA approved Eli Lilly’s Omvoh in Crohn’s disease, the company announced Wednesday, handing the drug its second indication after giving it a green light … ...
Shares of Eli Lilly have been falling in recent months, but that could spell opportunity. Investors appear to be concerned that a new government could impact its growth potential. The business is ...
Tim Smith has 20+ years of experience in the financial services industry, both as a writer and as a trader. Eli Lilly shares could remain under the microscope on Wednesday after falling sharply ...
SAN FRANCISCO — When Eli Lilly last year started offering lower-priced vials of its blockbuster obesity drug Zepbound, which were previously sold in injectable pens, it framed the move as a way ...
Eli Lilly (NYSE: LLY) saw its stock decline sharply by 6.5% on January 14, following the release of its fourth-quarter 2024 revenue guidance, which fell short of Wall Street expectations. The ...
Lilly plans to share its full Q4 2024 results on 6 February 2025. Credit: JHVEPhoto via Getty Images. Eli Lilly has announced a $400m reduction in its 2024 revenue forecast, marking a 3% shortfall ...
Employees are advised to complete this process promptly to access benefits under the Employment Linked Incentive (ELI) scheme. Why UAN activation is important? UAN, a unique 12-digit identifier ...
Check EPF balance. Update contact details. About the ELI scheme The ELI scheme aims to promote formal-sector employment and ensure direct benefit transfers (DBT) to employees’ Aadhaar-linked bank ...
Eli Lilly and Co. LLY Eli Lilly’s shares fell 6.59%, closing at $744.91. The stock had an intraday high of $784.23 and a low of $729, with a 52-week range of $612.7 to $972.53. The company ...